Toxicology of Silica Nanoparticles: an Update

Overview

Journal Arch Toxicol

Specialty Toxicology

Date 2017 Jun 3

PMID 28573455

Citations 146

Authors

Sivakumar Murugadoss

Dominique Lison

Lode Godderis

Sybille van den Brule

Jan Mast

Frederic Brassinne

Noham Sebaihi

Peter H Hoet

Affiliations

Soon will be listed here.

Abstract

Large-scale production and use of amorphous silica nanoparticles (SiNPs) have increased the risk of human exposure to SiNPs, while their health effects remain unclear. In this review, scientific papers from 2010 to 2016 were systematically selected and sorted based on in vitro and in vivo studies: to provide an update on SiNPs toxicity and to address the knowledge gaps indicated in the review of Napierska (Part Fibre Toxicol 7:39, 2010). Toxicity of SiNPs in vitro is size, dose, and cell type dependent. SiNPs synthesized by wet route exhibited noticeably different biological effects compared to thermal route-based SiNPs. Amorphous SiNPs (particularly colloidal and stöber) induced toxicity via mechanisms similar to crystalline silica. In vivo, route of administration and physico-chemical properties of SiNPs influences the toxicokinetics. Adverse effects were mainly observed in acutely exposed animals, while no significant signs of toxicity were noted in chronically dosed animals. The correlation between in vitro and in vivo toxicity remains less well established mainly due to improper-unrealistic-dosing both in vitro and in vivo. In conclusion, notwithstanding the multiple studies published in recent years, unambiguous linking of physico-chemical properties of SiNPs types to toxicity, bioavailability, or human health effects is not yet possible.

Citing Articles

Release of Crystalline Silica Nanoparticles during Engineered Stone Fabrication.

Rishi K, Ku B, Qi C, Thompson D, Wang C, Dozier A ACS Omega. 2025; 9(51):50308-50317.

PMID: 39741824 PMC: 11683610. DOI: 10.1021/acsomega.4c06437.

The Genetic and Epigenetic Toxicity of Silica Nanoparticles: An Updated Review.

Zheng M, Chen Z, Xie J, Yang Q, Mo M, Liu J Int J Nanomedicine. 2024; 19:13901-13923.

PMID: 39735322 PMC: 11681786. DOI: 10.2147/IJN.S486858.

Toxicity study of silica nanoparticles following 94-day repeated oral administration in Sprague Dawley rats.

Cao X, Xie B, Xu M, Li J, Dai X, Tian Y Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39601819 DOI: 10.1007/s00210-024-03639-x.

Silica Nanoparticle Exposure Caused Brain Lesion and Underlying Toxicological Mechanism: Route-Dependent Bio-Corona Formation and GSK3β Phosphorylation Status.

Wei W, Yang B, Zhu X, Liu X, Song E, Song Y Environ Health (Wash). 2024; 2(2):76-84.

PMID: 39474100 PMC: 11503913. DOI: 10.1021/envhealth.3c00119.

Benchmark dose determining airborne crystalline silica particles based on A549 lung-cell line survival in an in vitro study.

Rafieepour A, Shekarloo M, Ashtarinezhad A, Alimohammadi I, Panjali Z Sci Rep. 2024; 14(1):21458.

PMID: 39271741 PMC: 11399125. DOI: 10.1038/s41598-024-72607-5.

References

Athinarayanan J, Periasamy V, Alsaif M, Al-Warthan A, Alshatwi A . Presence of nanosilica (E551) in commercial food products: TNF-mediated oxidative stress and altered cell cycle progression in human lung fibroblast cells. Cell Biol Toxicol. 2014; 30(2):89-100. DOI: 10.1007/s10565-014-9271-8. View

Frohlich E, Samberger C, Kueznik T, Absenger M, Roblegg E, Zimmer A . Cytotoxicity of nanoparticles independent from oxidative stress. J Toxicol Sci. 2009; 34(4):363-75. DOI: 10.2131/jts.34.363. View

Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Matsuo K, Arimori A . Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application. Biomaterials. 2011; 32(11):2713-24. DOI: 10.1016/j.biomaterials.2010.12.042. View

Li L, Liu T, Fu C, Tan L, Meng X, Liu H . Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape. Nanomedicine. 2015; 11(8):1915-24. DOI: 10.1016/j.nano.2015.07.004. View

Zhang Q, Xu H, Zheng S, Su M, Wang J . Genotoxicity of mesoporous silica nanoparticles in human embryonic kidney 293 cells. Drug Test Anal. 2015; 7(9):787-96. DOI: 10.1002/dta.1773. View

Oh S, Kim B, Kim H . Comparison of nanoparticle exposures between fumed and sol-gel nano-silica manufacturing facilities. Ind Health. 2014; 52(3):190-8. PMC: 4209587. DOI: 10.2486/indhealth.2013-0117. View

Gong C, Tao G, Yang L, Liu J, He H, Zhuang Z . The role of reactive oxygen species in silicon dioxide nanoparticle-induced cytotoxicity and DNA damage in HaCaT cells. Mol Biol Rep. 2011; 39(4):4915-25. DOI: 10.1007/s11033-011-1287-z. View

Lison D, Thomassen L, Rabolli V, Gonzalez L, Napierska D, Seo J . Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Toxicol Sci. 2008; 104(1):155-62. DOI: 10.1093/toxsci/kfn072. View

Berg J, Romoser A, Figueroa D, Spencer West C, Sayes C . Comparative cytological responses of lung epithelial and pleural mesothelial cells following in vitro exposure to nanoscale SiO2. Toxicol In Vitro. 2012; 27(1):24-33. DOI: 10.1016/j.tiv.2012.09.002. View

10.

Hara K, Shirasuna K, Usui F, Karasawa T, Mizushina Y, Kimura H . Interferon-tau attenuates uptake of nanoparticles and secretion of interleukin-1β in macrophages. PLoS One. 2014; 9(12):e113974. PMC: 4259327. DOI: 10.1371/journal.pone.0113974. View

11.

Thomassen L, Rabolli V, Masschaele K, Alberto G, Tomatis M, Ghiazza M . Model system to study the influence of aggregation on the hemolytic potential of silica nanoparticles. Chem Res Toxicol. 2011; 24(11):1869-75. DOI: 10.1021/tx2002178. View

12.

Choi J, Zheng Q, Katz H, Guilarte T . Silica-based nanoparticle uptake and cellular response by primary microglia. Environ Health Perspect. 2010; 118(5):589-95. PMC: 2866671. DOI: 10.1289/ehp.0901534. View

13.

Xu Z, Chou L, Sun J . Effects of SiO2 nanoparticles on HFL-I activating ROS-mediated apoptosis via p53 pathway. J Appl Toxicol. 2011; 32(5):358-64. DOI: 10.1002/jat.1710. View

14.

Napierska D, Thomassen L, Vanaudenaerde B, Luyts K, Lison D, Martens J . Cytokine production by co-cultures exposed to monodisperse amorphous silica nanoparticles: the role of size and surface area. Toxicol Lett. 2012; 211(2):98-104. DOI: 10.1016/j.toxlet.2012.03.002. View

15.

Kasper J, Hermanns M, Bantz C, Maskos M, Stauber R, Pohl C . Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: comparison with conventional monocultures. Part Fibre Toxicol. 2011; 8(1):6. PMC: 3040689. DOI: 10.1186/1743-8977-8-6. View

16.

Maurer-Jones M, Lin Y, Haynes C . Functional assessment of metal oxide nanoparticle toxicity in immune cells. ACS Nano. 2010; 4(6):3363-73. DOI: 10.1021/nn9018834. View

17.

Hu Y, Gao J . Potential neurotoxicity of nanoparticles. Int J Pharm. 2010; 394(1-2):115-21. DOI: 10.1016/j.ijpharm.2010.04.026. View

18.

Napierska D, Rabolli V, Thomassen L, Dinsdale D, Princen C, Gonzalez L . Oxidative stress induced by pure and iron-doped amorphous silica nanoparticles in subtoxic conditions. Chem Res Toxicol. 2012; 25(4):828-37. DOI: 10.1021/tx200361v. View

19.

Guichard Y, Fontana C, Chavinier E, Terzetti F, Gate L, Binet S . Cytotoxic and genotoxic evaluation of different synthetic amorphous silica nanomaterials in the V79 cell line. Toxicol Ind Health. 2015; 32(9):1639-50. DOI: 10.1177/0748233715572562. View

20.

Donaldson K, Poland C, Schins R . Possible genotoxic mechanisms of nanoparticles: criteria for improved test strategies. Nanotoxicology. 2010; 4:414-20. DOI: 10.3109/17435390.2010.482751. View